Intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL ‐6‐mediated protection associated with cecal microbiota changes
Allergy · 2023-05 · 78 (5) · 1245-1257
DOI: 10.1111/all.15606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, online erschienen am 11.12.2022. Verfasst von Bilal Alashkar Alhamwe und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Medicine, member of the German Center for Lung Research (DZL) and the Universities of Giessen and Marburg Lung Center (UGMLC)…. Hauptthemen laut MEDLINE: Asthma, Microbiota. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Early‐life exposure to certain environmental bacteria including Acinetobacter lwoffii ( AL ) has been implicated in protection from chronic inflammatory diseases including asthma later in life. However, the underlying mechanisms at the immune‐microbe interface remain largely unknown.
Methods
The effects of repeated intranasal AL exposure on local and systemic innate immune responses were investigated in wild‐type and Il6 −/− , Il10 −/− , and Il17 −/− mice exposed to ovalbumin‐induced allergic airway inflammation. Those investigations were expanded by microbiome analyses. To assess for AL ‐associated changes in gene expression, the picture arising from animal data was supplemented by in vitro experiments of macrophage and T‐cell responses, yielding expression and epigenetic data.
Results
The asthma preventive effect of AL was confirmed in the lung. Repeated intranasal AL administration triggered a proinflammatory immune response particularly characterized by elevated levels of IL‐6, and consequently, IL‐6 induced IL‐10 production in CD4 + T‐cells. Both IL‐6 and IL‐10, but not IL‐17, were required for asthma protection. AL had a profound impact on the gene regulatory landscape of CD4 + T‐cells which could be largely recapitulated by recombinant IL‐6. AL administration also induced marked changes in the gastrointestinal microbiome but not in the lung microbiome. By comparing the effects on the microbiota according to mouse genotype and AL ‐treatment status, we have identified microbial taxa that were associated with either disease protection or activity.
Conclusion
These experiments provide a novel mechanism of Acinetobacter lwoffii ‐induced asthma protection operating through IL‐6‐mediated epigenetic activation of IL‐10 production and with associated effects on the intestinal microbiome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Laboratory Medicine, member of the German Center for Lung Research (DZL) and the Universities of Giessen and Marburg Lung Center (UGMLC), Philipps-University Marburg, Marburg, Germany.
- Institute for Tumor Immunology, Clinic for Hematology, Oncology and Immunology, Center for Tumor Biology, and Immunology (ZTI), Philipps University Marburg, Marburg, Germany.
- College of Pharmacy, International University for Science and Technology (IUST), Daraa, Syria.
- Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey, USA.
- Department of Medicine, Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Translational Inflammation Research Division & Core Facility for Single Cell Multiomics, member of the German Center for Lung Research (DZL) and the Universities of Giessen and Marburg Lung Center (UGMLC), Philipps-Univ…
ORCID-Profile: Bilal Alashkar Alhamwe, Zhan Gao, Fahd Alhamdan, Hani Harb, Jihad El Andari, Peter L Graumann, Holger Garn, Jörg Tost, Daniel P Potaczek, Martin J Blaser, Harald Renz
Förderung
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Alashkar Alhamwe, B., Gao, Z., Alhamdan, F., Harb, H., Pichene, M., Garnier, A., El Andari, J., Kaufmann, A., Graumann, P. L., Kesper, D., Daviaud, C., Garn, H., Tost, J., Potaczek, D. P., Blaser, M. J., & Renz, H. (2023). Intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL ‐6‐mediated protection associated with cecal microbiota changes. Allergy, 78(5), 1245-1257. https://doi.org/10.1111/all.15606
Vancouver
Alashkar Alhamwe B, Gao Z, Alhamdan F, Harb H, Pichene M, Garnier A, et al. Intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL ‐6‐mediated protection associated with cecal microbiota changes. Allergy. 2023;78(5):1245-1257. doi:10.1111/all.15606
BibTeX
@article{AlashkarAlhamwe2023,
author = {Alashkar Alhamwe, Bilal and Gao, Zhan and Alhamdan, Fahd and Harb, Hani and Pichene, Matthieu and Garnier, Abel and El Andari, Jihad and Kaufmann, Andreas and Graumann, Peter L and Kesper, Dörthe and Daviaud, Christian and Garn, Holger and Tost, Jörg and Potaczek, Daniel P and Blaser, Martin J and Renz, Harald},
title = {Intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL ‐6‐mediated protection associated with cecal microbiota changes},
journal = {Allergy},
year = {2023},
volume = {78},
number = {5},
pages = {1245--1257},
doi = {10.1111/all.15606}
}
EUVIMED